Acetylation of NDUFA13 at K7 Senses OXPHOS Dysfunction to Disrupt Prohibitin Scaffolds and Drive Cristae Remodelling in Heart Failure
- 1School of Medicine, Zhejiang University
Abstract
Mitochondrial cristae disintegration is a hallmark of heart failure, yet how oxidative phosphorylation (OXPHOS) dysfunction triggers this structural collapse remains unclear. Here we identify acetylation of the complex I subunit NDUFA13 at lysine 7 (K7) as a metabolic sensor coupling OXPHOS dysfunction to cristae remodelling. OXPHOS inhibition drove NDUFA13-K7 hyperacetylation, inducing conformational compaction and translocation to the intermembrane space. Acetylated NDUFA13 competitively engaged PHB2 through its coiled-coil domain, displacing PHB1 and disassembling prohibitin scaffolds. The acetylation-mimetic NDUFA13-K7Q induced cristae fragmentation in vitro, and cardiomyocyte-specific K7Q knock-in mice showed accelerated mortality and cristae loss under pressure overload, accompanied by impaired TCA cycle flux, defective fatty acid oxidation and selective depletion of polyunsaturated cardiolipins. These findings establish NDUFA13-K7 acetylation as a reversible switch converting bioenergetic failure into pathological cristae remodelling and metabolic reprogramming, highlighting therapeutic potential for targeted deacetylation.
Related
- Implication of a rare variant in OPA1 in Cardiac Pathophysiology: From Cristae Remodelling to Contractile Dysfunction
- Cardiomyocyte prohibitin ablation reprograms cardiac metabolism revealing a pathogenic role for mTORC1 in dilated cardiomyopathy
- Glutamine-regulated VCP acetylation creates a proteostasis vulnerability in RB1-deficient tumor
- Intestinal epithelial Casd1 regulates mucus sialic acid O-acetylation and limits tissue damage from large-intestinal mucosal insults
- Microtubule lattice conformation and integrity regulate α-tubulin acetylation
BibTeX
@misc{nan2026acetylation,
title = {{Acetylation of NDUFA13 at K7 Senses OXPHOS Dysfunction to Disrupt Prohibitin Scaffolds and Drive Cristae Remodelling in Heart Failure}},
author = {J. Nan and X. Yang and Y. Lin and J. Shen and H. Chen and Z. Xu and J. Ye and Y. Wang and D. Xiong and C. Ke and L. Zhu and X. Kong and Z. Zhong and T. Ren and J. Jiang and X. Wang and B. Wang and D. Zhao and Z.-z. Li and Z. Shao and B. Liu and X. He},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.26.761921},
url = {https://www.biorxiv.org/content/10.64898/2026.10.26.761921v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Acetylation of NDUFA13 at K7 Senses OXPHOS Dysfunction to Disrupt Prohibitin Scaffolds and Drive Cristae Remodelling in Heart Failure
AU - J. Nan
AU - X. Yang
AU - Y. Lin
AU - J. Shen
AU - H. Chen
AU - Z. Xu
AU - J. Ye
AU - Y. Wang
AU - D. Xiong
AU - C. Ke
AU - L. Zhu
AU - X. Kong
AU - Z. Zhong
AU - T. Ren
AU - J. Jiang
AU - X. Wang
AU - B. Wang
AU - D. Zhao
AU - Z.-z. Li
AU - Z. Shao
AU - B. Liu
AU - X. He
PY - 2026
DA - 2026/10/26
PB - bioRxiv
DO - 10.64898/2026.10.26.761921
UR - https://www.biorxiv.org/content/10.64898/2026.10.26.761921v1
AB - Mitochondrial cristae disintegration is a hallmark of heart failure, yet how oxidative phosphorylation (OXPHOS) dysfunction triggers this structural collapse remains unclear. Here we identify acetylation of the complex I subunit NDUFA13 at lysine 7 (K7) as a metabolic sensor coupling OXPHOS dysfunction to cristae remodelling. OXPHOS inhibition drove NDUFA13-K7 hyperacetylation, inducing conformational compaction and translocation to the intermembrane space. Acetylated NDUFA13 competitively engaged PHB2 through its coiled-coil domain, displacing PHB1 and disassembling prohibitin scaffolds. The acetylation-mimetic NDUFA13-K7Q induced cristae fragmentation in vitro, and cardiomyocyte-specific K7Q knock-in mice showed accelerated mortality and cristae loss under pressure overload, accompanied by impaired TCA cycle flux, defective fatty acid oxidation and selective depletion of polyunsaturated cardiolipins. These findings establish NDUFA13-K7 acetylation as a reversible switch converting bioenergetic failure into pathological cristae remodelling and metabolic reprogramming, highlighting therapeutic potential for targeted deacetylation.
ER -